{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:45:47Z","timestamp":1789069547195,"version":"build-2803163510"},"reference-count":52,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803612"],"award-info":[{"award-number":["81803612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BioMed Research International"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>. L\u2010carnitine mediates the utilization of fatty acids and glucose in the myocardium. The potential of L\u2010carnitine in managing dilated cardiomyopathy (DCM) in patients has been extensively reported, with additional benefits. <jats:italic>Objective<\/jats:italic>. This meta\u2010analysis purposed to explore the clinical efficacy of L\u2010carnitine therapy on DCM patients. <jats:italic>Methods<\/jats:italic>. We searched publications up to May 2020 from several databases including PubMed, Embase, Cochrane Library, Chinese Biomedical (CBM) database, Chinese Science and Technology Periodicals database (VIP), Chinese National Knowledge Infrastructure (CNKI) database, and Wanfang database. Subsequently, publications that met the inclusion criteria were systematically evaluated by two independent reviewers. <jats:italic>Results<\/jats:italic>. A total of 23 RCTs conducted in China with 1455 DCM patients were included in this study. In the meta\u2010analysis, L\u2010carnitine therapy was associated with a considerable improvement in the overall efficacy (RR = 1.28, 95% CI (1.21\u20101.36), <jats:italic>P<\/jats:italic> &lt; 0.0001), left ventricular ejection fraction (LVEF) (MD = 6.16<jats:italic>%<\/jats:italic>, 95% CI (4.50, 7.83), <jats:italic>P<\/jats:italic> &lt; 0.0001), and cardiac output (CO) (MD = 0.88\u2009L\/min, 95% CI (0.51, 1.25), <jats:italic>P<\/jats:italic> &lt; 0.0001) as compared to the control group. Moreover, L\u2010carnitine therapy significantly decreased left ventricular end\u2010diastolic dimension (LVEDD) (MD = \u22122.53, 95% CI (\u20103.95, \u20101.12), <jats:italic>P<\/jats:italic> = 0.0005), brain natriuretic peptide (BNP) (SMD = \u22121.71\u2009ng\/L, 95% CI (\u20103.02, \u20100.40), <jats:italic>P<\/jats:italic> = 0.01), and the transforming growth factor\u2010beta (TGF\u2010<jats:italic>\u03b2<\/jats:italic>1) (MD = \u221256.78\u2009ng\/L, 95% CI (\u201066.02, \u201047.53), <jats:italic>P<\/jats:italic> &lt; 0.0001). <jats:italic>Conclusions<\/jats:italic>. L\u2010carnitine potentially enhanced the therapeutic efficiency in DCM patients. Following weaknesses in the evidence due to low methodological quality and high clinical heterogeneity in the included studies, well\u2010designed trials are recommended.<\/jats:p>","DOI":"10.1155\/2021\/9491615","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T19:53:35Z","timestamp":1610567615000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of L\u2010Carnitine for Dilated Cardiomyopathy: A Meta\u2010Analysis of Randomized Controlled Trials"],"prefix":"10.1155","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2286-3400","authenticated-orcid":false,"given":"Yayun","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianze","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8118-7545","authenticated-orcid":false,"given":"Zhiyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-9571","authenticated-orcid":false,"given":"Qiaomei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"e_1_2_10_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000455"},{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.590"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12944"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90901-A"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.027134"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309396"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31713-5"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-016-2250-8"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.103917"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-7-30"},{"key":"e_1_2_10_11_2","volume-title":"Practical department of internal medicine, vol. 9","author":"Haozhu C.","year":"2001"},{"key":"e_1_2_10_12_2","volume-title":"Internal medicine, vol. 159","author":"Rengao Y.","year":"2004"},{"key":"e_1_2_10_13_2","volume-title":"Diagnosis and treatment of cardiomyopathy","author":"Zhishou Z.","year":"2001"},{"key":"e_1_2_10_14_2","volume-title":"Guidelines and Guidelines for the Prevention and Treatment of Cardiovascular Disease","author":"Chinese Association of Cardiology, Chinese Association of Cardiomyopathy","year":"2009"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-018-0284-2"},{"key":"e_1_2_10_16_2","first-page":"9","article-title":"Effects of L-carnitine on BNP and RDW levels in children with dilated cardiomyopathy","volume":"28","author":"Fangjie W.","year":"2018","journal-title":"Journal of Shanxi Medical College for Continuing Education"},{"key":"e_1_2_10_17_2","first-page":"1250","article-title":"Therapeutic effects of levocarnitine on children with dilated cardiomyopathy","volume":"39","author":"Shengxiang Y.","year":"2019","journal-title":"Journal of Clinical Pathology"},{"key":"e_1_2_10_18_2","first-page":"117","article-title":"Effects of L-carnitine combined with bisoprolol on cardiac function and plasma levels of BNP and TGF-\u03b21 in patients with dilated cardiomyopathy","volume":"28","author":"Juntao A.","year":"2019","journal-title":"Henan Medical Research"},{"key":"e_1_2_10_19_2","first-page":"701","article-title":"Preliminary efficacy of levocarnitine in the treatment of severe heart failure with dilated cardiomyopathy","volume":"11","author":"Qun C.","year":"2009","journal-title":"Journal of Chinese Physician"},{"key":"e_1_2_10_20_2","article-title":"Efficacy of L-carnitine in improving cardiac function in patients with primary dilated cardiomyopathy","volume":"33","author":"Cunzhong F.","year":"2007","journal-title":"Jiangsu Medical Journal"},{"key":"e_1_2_10_21_2","article-title":"Clinical observation of L-carnitine in the treatment of heart failure in dilated cardiomyopathy","volume":"8","author":"Tianfu F.","year":"2006","journal-title":"Zhejiang Clinical Medical Journal"},{"key":"e_1_2_10_22_2","first-page":"603","article-title":"The therapeutic effect of levocarnitine on chronic heart failure due to dilated cardiomyopathy","volume":"8","author":"Qiaojuan H.","year":"2009","journal-title":"Chinese Journal of Difficult and Complicated Cases"},{"key":"e_1_2_10_23_2","first-page":"1966","article-title":"Efficacy of L-carnitine on dilated cardiomyopathy","volume":"29","author":"Wenwei H.","year":"2013","journal-title":"Occupation and Health"},{"key":"e_1_2_10_24_2","first-page":"463","article-title":"Clinical observation on L-carnitine in dilated cardiomyopathy","volume":"27","author":"Jinshun L.","year":"2013","journal-title":"Chinese Journal of School Doctor"},{"key":"e_1_2_10_25_2","first-page":"44","article-title":"Analysis of the clinical efficacy of L-carnitine in the treatment of dilated cardiomyopathy with heart failure","volume":"6","author":"Ming L.","year":"2015","journal-title":"Medical Science"},{"key":"e_1_2_10_26_2","first-page":"325","article-title":"Effect of levocarnitine on carnitine set of patients with dilated cardiomyopathy","volume":"24","author":"Shengnan L.","year":"2013","journal-title":"China Pharmacy"},{"key":"e_1_2_10_27_2","first-page":"1445","article-title":"Observation on the efficacy of L-carnitine in the treatment of heart failure in dilated cardiomyopathy","volume":"26","author":"Yunjian L.","year":"2013","journal-title":"Journal of Medical Theory and Practice"},{"key":"e_1_2_10_28_2","first-page":"118","article-title":"Effects of L-carnitine on cardiac function and TGF-\u03b2 levels in patients with dilated cardiomyopathy","volume":"8","author":"Zengbiao L.","year":"2014","journal-title":"Chinese Journal of Modern Drug Application"},{"key":"e_1_2_10_29_2","first-page":"51","article-title":"Effect of L-carnitine on dilated cardiomyopathy in 36 cases","volume":"18","author":"Zhixian Q.","year":"2009","journal-title":"China Pharmaceuticals"},{"key":"e_1_2_10_30_2","first-page":"59","article-title":"Effects of L-carnitine on metabolic remodeling and cardiac function in patients with dilated cardiomyopathy","volume":"18","author":"Tao Z. Q.","year":"2009","journal-title":"Journal of Jiangsu University(Medicine Edition)"},{"key":"e_1_2_10_31_2","first-page":"2639","article-title":"Effects of L-carnitine on cardiac function and TGF-\u03b21 level in patients with dilated cardiomyopathy","volume":"33","author":"Erling W.","year":"2013","journal-title":"Chinese Journal of Gerontology"},{"key":"e_1_2_10_32_2","first-page":"1079","article-title":"Effect of L-carnitine on plasma NT-ProBNP in dilated cardiomyopathy","volume":"43","author":"Jianxia W.","year":"2014","journal-title":"Shaanxi Medical Journal"},{"key":"e_1_2_10_33_2","first-page":"2319","article-title":"The effect of levocarnitine on cardiac function in patients with dilated cardiomyopathy","volume":"20","author":"Yong X.","year":"2013","journal-title":"Chinese Journal of Primary Medicine and Pharmacy"},{"key":"e_1_2_10_34_2","first-page":"165","article-title":"Indigenous L-carnitine in treatment of dilated cardiomyopathy","volume":"6","author":"Zhiyu Z.","year":"2007","journal-title":"Chinese Journal of Multiple Organ Diseases in the Elderly"},{"key":"e_1_2_10_35_2","article-title":"Clinical observation of L-carnitine in treating chronic heart failure with dilated cardiomyopathy","volume":"13","author":"Xiuqing Z.","year":"2007","journal-title":"Chinese Magazine of Clinical Medicinal Professional Research"},{"key":"e_1_2_10_36_2","first-page":"150","article-title":"Efficacy of L-carnitine in improving cardiac function in patients with primary dilated cardiomyopathy","volume":"16","author":"Chunli Z.","year":"2010","journal-title":"Contemporary Medicine"},{"key":"e_1_2_10_37_2","first-page":"226","article-title":"Clinical effect of conventional anti-heart failure drugs combine with levocarnitine in the treatment of dilated cardiomyopathy and heart fei lure patients","volume":"7","author":"Hou Z.","year":"2009","journal-title":"Chinese Medicine Modern Distance Education in China"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-018-1061-0"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6274854"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-018-1214-5"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv510"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.110.973826"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1819794"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.5603\/cj.a2018.0143"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007142919941"},{"key":"e_1_2_10_46_2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2223\/JPED.1387","article-title":"The role of L-carnitine in nutritional status and echocardiographic parameters in idiopathic dilated cardiomyopathy in children","volume":"81","author":"Azevedo V. M.","year":"2005","journal-title":"Journal of Pediatrics"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.3923\/jms.2006.800.805"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-018-9756-2"},{"key":"e_1_2_10_49_2","first-page":"81","article-title":"Myocardial energetics and the role of micronutrients in heart failure: a critical review","volume":"6","author":"Wong A. P.","year":"2016","journal-title":"American Journal of Cardiovascular Disease"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.12.015"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12163"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2004.07.009"}],"container-title":["BioMed Research International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2021\/9491615.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2021\/9491615.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2021\/9491615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T14:20:24Z","timestamp":1735654824000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2021\/9491615"}},"subtitle":[],"editor":[{"given":"Carlos R.","family":"Bueno Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1155\/2021\/9491615"],"URL":"https:\/\/doi.org\/10.1155\/2021\/9491615","archive":["Portico"],"relation":{},"ISSN":["2314-6133","2314-6141"],"issn-type":[{"value":"2314-6133","type":"print"},{"value":"2314-6141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"2020-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"9491615"}}